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Abstract  
Objective  
To develop a taxonomy of explanations for patients with persistent physical symptoms. 
Methods  
We analysed ĚŽĐƚŽƌƐ ?explanations from two studies of a moderately-intensive consultation 
intervention for patients with multiple, often  “ŵĞĚŝĐĂůůǇ-unexplained, ?physical symptoms. We used 
a constant comparative method to develop a taxonomy which was then applied to all verbatim 
explanations. 
Results  
We analysed 138 explanations provided by five general practitioners to 38 patients. The taxonomy 
comprised explanation types and explanation components. Three explanation types described the 
overall structure of the explanations: Rational Adaptive, Automatic Adaptive, and Complex. These 
differed in terms of who or what was given agency within the explanation. Three explanation 
components described the content of the explanation: Facts  W generic statements about normal or 
dysfunctional processes; Causes  W person-specific statements about proximal or distal causes for 
symptoms; Mechanisms  Wprocesses by which symptoms arise or persist in the individual. Most 
explanations conformed to one type and contained several components. 
Conclusions  
This novel taxonomy for classifying clinical explanations permits detailed classification of explanation 
types and content. Explanation types appear to carry different implications of agency.  
Practice Implications 
The taxonomy is suitable for examining explanations and developing prototype explanatory scripts in 
both training and research settings. 
Keywords 
medically unexplained symptoms, somatoform disorders, explanation, reassurance, primary care 
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1. Background 
Physical symptoms which cannot be explained by organic disease are present in 40% of patients 
consulting GPs[1], are the reason for consultation in 20% [2-4] and account for up to 65% of referrals 
to specialists[5]. These so-called medically unexplained symptoms (MUS) may occur singly (e.g. 
dizziness), in syndrome clusters (e.g. fibromyalgia), or in combination [6]. Most symptoms are 
transient, but approximately 2% of adults experience persistent or recurrent symptoms which are 
associated with increased primary care consulting and referral to secondary care [7,8].   
DeƐƉŝƚĞƚŚĞƚĞƌŵ “ŵĞĚŝĐĂůůǇ-unexplained ?, developments in neuroscience and other disciplines 
mean it is now possible to explain many symptoms using models which integrate biological, 
psychological and social processes [6,9,10]. These models are increasingly similar to those used to 
describe chronic pain, with processes such as central sensitization  W originally worked out for pain - 
now being applied to other symptoms [11].  The DSM-5 psychiatric classification [12] now includes 
Somatic Symptom Disorder which no longer requires that symptoms are medically unexplained, and 
ƚŚĞƌĞŝƐŝŶĐƌĞĂƐŝŶŐƌĞĐŽŐŶŝƚŝŽŶƚŚĂƚƚŚĞĚŝĐŚŽƚŽŵǇďĞƚǁĞĞŶ “ĞǆƉůĂŝŶĞĚ ?ĂŶĚ “ƵŶĞǆƉůĂŝŶĞĚ
ƐǇŵƉƚŽŵƐ ?ŝƐĨĂůƐĞ ? [13]  Given these developments in models and changes in classifications, there is 
a strong case for developing explanations which permit the biological and the psycho-social to co-
exist in a wide range of symptoms and settings [14].  
 
Despite this increase in knowledge and evolution of classification there is a gap between the 
expectations of patients with persistent physical symptoms and what they receive from clinicians in 
terms of explanation [15-17]. DĂŶǇƉĂƚŝĞŶƚƐĚŝƐůŝŬĞƚĞƌŵƐƐƵĐŚĂƐ ?ŵĞĚŝĐĂůůǇƵŶĞǆƉůĂŝŶĞĚ ?ĂŶĚ
 ?ƐŽŵĂƚŝĐ ?ĂŶĚƉƌĞĨĞƌ terms such as persistent physical symptoms [18,19]. For some patients the lack 
of appropriate terminology and clear explanation for their symptoms delegitimises their condition.  
For others, older models of explanation such as somatisation are rejected as too simplistic [20] or as 
a threat to their integrity [21].  
Patients enter consultations with possible explanations of their own[22], and consultations should 
involve a process of negotiating explanation and co-constructing meaning. However, doctors 
struggle to provide explanations for MUS [23] and in practice use a very limited repertoire of 
explanation with patients [24]. We have recently argued, following Salmon [25], that this does not 
need to be the case: ŝƚŝƐƉŽƐƐŝďůĞƚŽĐŽŶƐƚƌƵĐƚĂŶĚĚĞůŝǀĞƌ “ƌĂƚŝŽŶĂů ?ĞǆƉůĂŶĂƚŝŽŶƐĨŽƌƐǇŵƉƚŽŵƐ [26].  
In order to do so, we need to first understand how such potentially useful explanations for 
symptoms are constructed.  
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Here we report an analysis of data combined from two studies of the Symptoms Clinic Intervention 
(SCI), a moderately-intensive, primary care based consultation intervention, comprising one long- 
and three moderate-length consultations, for patients with multiple, largely  “ŵĞĚŝĐĂůůǇ
ƵŶĞǆƉůĂŝŶĞĚ ?, physical symptoms which aimed to provide explanations for symptoms as a means of 
ǀĂůŝĚĂƚŝŶŐƉĂƚŝĞŶƚƐ ?ĞǆƉĞƌŝĞŶĐĞĂŶĚas a link to advice about self-management [27,28]. In this 
analysis we aimed to rigorously develop a taxonomy for the explanations for  “ŵĞĚŝĐĂůůǇ
ƵŶĞǆƉůĂŝŶĞĚ ? symptoms by doctors which would be generalisable beyond the current studies. 
Development and use of a taxonomy allows exemplars of behaviour and communication to be 
identified which in turn permits their evaluation [29,30]. We required that the taxonomy be 
inclusive, flexible and suitable for use in both describing and developing explanations for different 
clinical settings.  
 
2. Methods 
2.1 Study design, setting & participants 
We conducted an in-depth secondary analysis of the content of UK general practitŝŽŶĞƌƐ ? ?'WƐ ? ?
ĞǆƉůĂŶĂƚŝŽŶƐĨŽƌƉĂƚŝĞŶƚƐ ?persistent physical symptom(s). The data for this analysis came from two 
developmental studies of the SCI. [27,28]  
The first study of the SCI, Multiple Symptoms Study 1 (MSS1), was a pilot randomised controlled trial 
of the SCI versus usual care conducted with a single GP, who was the developer of the SCI [27]. Its 
primary aim was to test the acceptability and feasibility of the SCI and of trial procedures such as 
recruitment and randomisation. The second study, Multiple Symptoms Study 2 (MSS2), was an 
observational study to examine delivery of the SCI by four GPs, to patients in their own practice, 
after participating in a two-day training programme [28].  All consultations from both studies were 
recorded and transcribed: those transcriptions provided the research material for this analysis. 
Detailed methods of both studies have been described elsewhere [27,28]. Here, we provide a brief 
summary. 
For both studies, potential patients were identified using a two-stage procedure of clinical database 
search for diagnostic codes and referrals, followed by a mailed questionnaire. This included the 
Patient Health Questionnaire-15 (PHQ-15) which measures the impact of symptoms which are 
commonly medically unexplained (e.g. nausea/gas/indigestion, pain in arms/legs/joints). Eligible 
patients had one or more diagnostic codes indicative of MUS (e.g. irritable bowel syndrome, 
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fibromyalgia), referrals to specialists within the preceding three years, and a PHQ- ? ?ƐĐŽƌĞŽĨш ? ? ?
2.2.  
Symptoms Clinic Intervention 
The SCI consists of a series of three or four extended consultations. It comprises four key 
components of Recognition, Explanation, Action, and Learning. The first consultation lasts 
approximately 50 minutes and centres on Recognition - active listening and acknowledgement of the 
ƉĂƚŝĞŶƚ ?ƐĂĐĐŽƵŶƚŽĨŝůůŶĞƐƐĂŶĚŝƚƐŝŵƉĂĐƚŽŶĚĂŝůǇůŝǀŝŶŐ ?ExplanationƐĨŽƌƉĂƚŝĞŶƚƐ ?ƐǇŵƉƚŽŵƐĂƌĞ
proposed in the first or in subsequent follow-up consultations (which last approximately 20 minutes 
each) and ŝŶǀŽůǀĞŵĂŬŝŶŐĐŽŶƐƚƌƵĐƚŝǀĞƐĞŶƐĞŽĨĂƉĂƚŝĞŶƚ ?ƐƌĞƉŽƌƚĞĚƐǇŵptoms in terms of 
physiological, and/or psychosocial mechanisms. GPs and patients then negotiate Action: symptom 
management strategies that are concordant with the explanations previously discussed. Throughout 
the consultations, GPs and patients Learn what does or does not make sense or work for the patient 
and their understanding and management of their symptoms.  
2.3 Data collection 
One hundred and twelve consultations (43 MSS1, 69 MSS2) with 39 patients were audio-recorded 
and transcribed verbatim for subsequent analysis.  
2.4 Ethical approval 
Both studies had appropriate ethical approval: Lothian Research Ethics Committee (reference 
09/S1102/34) & North East Scotland Research Ethics Committee (reference 14/NS/1014).  
2.5 Data analysis 
2.5.1 Extraction of Explanations 
As the aim of the current study was to develop a taxonomy of ƉŚǇƐŝĐŝĂŶƐ ?ĞǆƉůĂŶĂƚŝons explanation 
for symptoms, it was important that the analysis focus on explanation as the primary unit of inquiry; 
previous work has illustrated that analysis at this level can provide insights about the development 
and delivery of explanation [21,31]. We defined explanations within the consultation transcripts as a 
sequence of utterances by the doctor (with or without input from the patient) which began at the 
point the GP introduced ĂŶĞǆƉůĂŶĂƚŝŽŶŽĨŚŽǁƚŚĞƉĂƚŝĞŶƚ ?ƐƐǇŵƉƚŽŵƐŵŝŐŚƚďĞƵŶĚĞƌƐƚŽŽĚĂŶĚ
ended when the conversation moved to another aspect of the consultation (e.g. Action). We 
extracted all these instances of explanations from the full transcripts for detailed analysis. 
2.5.2 Classification of whole explanations 
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We initially attempted to develop a classification at the level of each explanation (using the 
definition in section 2.5.1) by summarising each verbatim section from MSS1, where possible 
retaining the natural language of the GP. One researcher (LM) then analysed these summaries 
thematically to identify potential categories to describe the content of the explanations. The 
research team (CB, VD, AE, JC) then conducted a group sort analysis of the explanations, which 
involved discussing the core features and themes of each explanation and classifying them based on 
similarities and differences to other explanations. During this sorting process it became apparent 
that most explanations had multiple components, that common components could be recognised 
across otherwise different explanations, and that many explanations could belong to more than one 
category.  
2.5.3 Classification of explanation features 
Following the difficulty in allocating whole explanations to single categories within the thematic and 
group sort analyses, we developed a new classification of explanation features. These explanation 
features existed on two levels: the overall explanation type, and phrases or sequences of phrases 
which represented identifiable components of the explanation. In developing this classification we 
used a constant comparative method [32]. Firstly, two researchers (LM, CB) coded the explanation 
summaries ? type and components based on the themes identified during the previous group sort 
and thematic analyses . From this we further developed and defined the codes for explanation types 
and components. Next we applied a cyclical process of coding verbatim explanations from MSS2 
(coded as transcripts were received from the study) against the set of codes, followed by discussion 
between researchers; the codes were further developed and refined when necessary. Initial coding 
was conducted by LM and a random sample of 12 (16%) explanations from different doctors in MSS2 
were independently coded by CB; difficulties in coding and disagreements were resolved by 
discussion between LM and CB.  
The coding structure was continuously developed until the components could be clearly described 
with definitions for each explanation component. At that point we finalised the taxonomy and 
applied it afresh to all verbatim explanations from both MSS1 and MSS2. 
 ? ? ? ? ?ZĞůĂƚŝŽŶƐŚŝƉŽĨĚŽĐƚŽƌƐ ?ĞǆƉůĂŶĂƚŝŽŶƐƚŽƉĂƚŝĞŶƚ ?ƐĞǆƉůĂŶĂƚŝŽŶƐĂŶĚĚŝĂůŽŐƵĞ 
All of the ĚŽĐƚŽƌƐ ?explanations which we analysed occurred within larger dialogues between doctor 
and patient. They represented either 1) hypotheses based on the preceding dialogue or 2) 
performative speech acts [14] whereby an explanation was presented as declaration. We have 
conducted a separate analysis of the dialogue in relation to explanations (den Boeft, submitted for 
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publication) including the ways they are negotiated within consultations and the ways that patients 
respond to them and these are not reported here.  
 
3. Results 
The final taxonomy was derived from 138 explanations from 38 patients receiving the SCI (63 
explanations from MSS1 and 75 from MSS2); one patient in MSS2 experienced a change in clinical 
condition which led to withdrawal from the study before receiving any explanations. Explanations 
were presented for symptoms of musculoskeletal pain, fibromyalgia, headaches, fatigue, 
gastrointestinal issues, breathlessness, chest tightness/palpitations, insomnia, environmental 
sensitivities, and tinnitus. GPs provided a median of 3 (range 1 to 9) explanations per patient over 
the course of the SCI.. The taxonomy comprised explanation types (codes relating to the explanation 
structure) and components (codes relating to individual phrases or sequences of phrases within the 
explanation). These are described below and summarised in Table 1. 
3.1 Explanation Types 
Explanation types summarise the overall emphasis of the symptom explanation and in particular 
they relate to the location of responsibility for, or agency over, the symptom. We consider them as a 
discursive structure which holds the more detailed mechanistic components. We identified three 
different explanation types termed Rational Adaptive, Automatic Adaptive, and Complex which are 
described below. Most 102 (73.9%) explanation sequences could be allocated to a single explanation 
type. Twenty (14.5%) explanations did not fit any of these three types and 16 (11.6%) included 
elements of two types. Only one patient with explanations had none which could be allocated to an 
explanation type. The following examples of explanations reflect either direct quotations from the 
GP or sections of dialogue between GP and patient in which the explanation was proposed. 
 
 ?Rational Adaptive ? explanations were present in 31 (22.5%) explanations and used with 18 (50%) 
patients. They described ƉĂƚŝĞŶƚƐ ?ƐǇŵƉƚŽŵƐŝŶƚĞƌŵƐŽĨbiological or psychosocial processes which 
were understandable but also served to cause and/or perpetuate symptoms. These explanations 
were similar to those commonly used in cognitive therapies: the symptom was real and 
understandable, but ultimately maladaptive. In rational adaptive explanations, agency  W the 
responsibility for the symptom and for action  W resides with the individual.  In the following example 
ŽĨĐŽŶƐƵůƚĂƚŝŽŶĚŝĂůŽŐƵĞ ?ƚŚĞ'WƵƐĞƐĂƌĂƚŝŽŶĂůĂĚĂƉƚŝǀĞĞǆƉůĂŶĂƚŝŽŶĂƌŽƵŶĚ “ďŽŽŵ-or-ďƵƐƚ ?ĞŶĞƌŐǇ
balance. 
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GP: So thinking about energy levels ... people with fibromyalgia are commonly 
describing where they have good days and get lots ĚŽŶĞ ? ?ƚŚĞǇƐĞĞƚŚĂƚƚŚĞƉĂŝŶƐ
ĂƌĞŶ ?ƚƚŽŽďĂĚĂŶĚƚŚĞǇƚƌǇĂŶĚƌƵƐŚĂŶĚŐĞƚĞǀĞƌǇƚŚŝŶŐĚŽŶĞ ? 
F: zĞĂŚ ?ďĞĐĂƵƐĞǇŽƵ ?ƌĞĨĞĞůŝŶŐŽŬĂǇ ?-ish. 
GP: zĞĂŚ ?ĂŶĚƚŚĞŶĂůƚĞƌŶĂƚĞůǇǇŽƵ ?ůůŚĂǀĞďĂĚĚĂǇƐ ?ǁŚĞƌĞƚŚĞƉĂŝŶƐ ?ǁŚĞƌĞƚŚĞ
ƉĂŝŶƐĂƌĞďĂĚ ?ĂŶĚǇŽƵĐĂŶ ?ƚƌĞĂůůǇŐĞƚ, get very much done. 
F: Yeah, definitely. 
GP: And I think that, that cycle, um, where you have these alternations, and the 
ƐƵďƐĞƋƵĞŶƚǀĂƌǇŝŶŐŝŶǇŽƵƌůĞǀĞůƐŽĨĂĐƚŝǀŝƚǇ ?ĂůƚŚŽƵŐŚŝƚ ?ƐǀĞƌǇ ?ǀĞƌǇƵŶĚĞƌƐƚĂŶĚĂďůĞ ?
ŝƚ ?ƐƉƌŽďĂďůǇŽŶĞŽĨƚŚĞƚŚŝŶŐƐƚŚĂƚ ?ƐǁŽƌŬŝŶŐ ?ƚŽŬĞĞƉǇŽƵƌĞŶĞƌŐǇůĞǀĞůƐĂůŝƚƚůĞďŝƚ
lower than they need to be. 
(MSS2, GP C) 
,ĞƌĞƚŚĞŵĞĐŚĂŶŝƐŵŽĨĂŶŝŶĚŝǀŝĚƵĂů ?Ɛ ?ƌĂƚŝŽŶĂů ?ƌĞƐƉŽŶƐĞƚŽĂƐŚŽƌƚ-lived respite from symptoms is 
taken over by processes that ultimately serve to perpetuate symptoms. The implication is that these 
processes (activity avoidance and exhaustion), over which the patient has agency, are the main 
perpetuating factors. 
 
 ?Automatic Adaptive ? explanations were found in 51 (37.0%) explanations and used with 24 (66.6%) 
patients. They were similar to  ?Rational Adaptive ? explanations in that there was a clear link between 
a stimulus (process) and its consequence (symptoms). However, these explanations made sense of 
ƉĂƚŝĞŶƚƐ ?ƐǇŵƉƚŽŵƐ in terms of involuntary processes, typically described in bodily (physiological) 
terms rather than mental (psychological) terms.  These processes were described as normally 
adaptive, automatic mechanisms that were now acting maladaptively to generate and/or perpetuate 
symptoms. Within these explanations, agency was given to the body or brain. 
  ?ĨĂƚŝŐƵĞŝƐĂŶŽƚŚĞƌŽĨƚŚĞƐĞƐǇŵƉƚŽŵƐƚŚĂƚŝƐŐƌĞĂƚŝŶƚŚĞĞĂƌůǇƐƚĂŐĞƐŝĨǇŽƵŚĂǀĞĂŶ
ŝůůŶĞƐƐŽƌĂŶŝŶũƵƌǇ ?ŝƚ ?ƐǇŽƵƌďŽĚǇ ?ƐǁĂǇŽĨƐĂǇŝŶŐǇŽƵŶĞĞĚƚŽƌĞƐƚďĞĐĂƵƐĞǇŽƵŶĞĞĚ
to convert all your energy into healing, fighting this infection or whatever, really 
ƵƐĞĨƵůǁŚĞŶƐŽŵĞƚŚŝŶŐ ?ƐŐŽŶĞǁƌŽŶŐ ?ďƵƚĂŐĂŝŶŝƚ ?ƐŽƵƚůŝǀĞĚŝƚƐƵƐĞŝŶƉĞŽƉůĞǁŝƚŚ ?
you know, got chronic fatigue really and it's striking that balance between what its 
original message is 'rest, don't do anything' and how helpful that is when it's become 
pervasive symptoms?... (MSS2, GP A) 
 
9 
 
Here the mechanism of recuperative fatigue, and its maladaptive persistence, is located in the body. 
The automatic adaptive explanation type places the causal responsibility away from the person. 
Instead it has the potential to recreate the distance between patient and problematic body which is 
typical of a conventional biomedical clinical interaction. Thus while the patient is not directly 
responsible, there is the opportunity for therapeutic action, either by patient, clinician or both, to 
regain control over symptoms.  
 
 ?ŽŵƉůĞǆ ?ĞǆƉůĂŶĂƚŝŽŶƐwere present in 52 (37.7%) explanations and used with 24 (66.6%) patients. 
They differed from the previous two types in that there was no clear link between a stimulus and its 
consequence, i.e. a process or symptom could spontaneously occur without any original apparent 
adaptive purpose or rationale. These explanations located symptom generation within the intricate 
functioning and/or interplay of different bodily systems (such as the immune system or 
hypothalamus pituitary adrenal axis). These explanations gave agency to systems which were 
complex and therefore, to an extent, unknowable; GPs often described  “ǀŝĐŝŽƵƐĐŝƌĐůĞs ?ǁŚĞƌĞ
systems, symptoms and their consequences fed into one another within an autopoeitic cycle.  
 
GP  ?ŽŶĞŽĨƚŚĞƚŚŝŶŐƐƚŚĂƚ ?ƐŽƌƚŽĨ ?ĚƌŝǀĞƐƚŚŝƐƐǇŵƉƚŽŵĂƉƉƌŽĂĐŚŝƐƚŚĞǀŝĞǁƚŚĂƚ
symptoms and the processes that cause them can, kind of, have a life of their own 
separately from a direct cause. 
Patient Cause, yes. 
GP So a pattern of immune system behaviour can set up, that it no longer needs 
a full-ďůŽǁŶĨŝŐŚƚǁŝƚŚĂĨůƵǀŝƌƵƐƚŽ ?ŬŝŶĚŽĨ ?ƐĞƚƚŚĞƚŚŝŶŐƵƉ ?/ƚ ?ƐůŝŬĞŝƚ ?ƐŚĂƉƉĞŶĞĚƐŽ
often or been so strongly imprinted that it just... once it starts, it just needs to be 
tipped off and it just... 
Patient It goes again. 
GP Begins, or pain and all that, kind of, pain cluster of stuff, and it, kind of, 
ƐĞĞŵƐƚŚĂƚƚŚĞƌĞ ?ƐĂĨĞǁ ?ŬŝŶĚŽĨ ?ŬĞǇĞǀĞŶƚƐƚŚĂƚůĞĂǀĞƚŚ ŝƌŵĂƌŬ in your body and 
not literally but leave their mark in terms of the way systems work, and the way your 
ŵĞŵŽƌǇǁŽƌŬƐ ?ĂŶĚƚŚĞǁĂǇǇŽƵƌďŽĚǇ ?ŬŝŶĚŽĨ ?ŐŽĞƐ ?ŽŚ / ?ǀĞƐĞĞŶƚŚĂƚďĞĨŽƌĞ ?/ŬŶŽǁ
what happens next, uh-oh. (MSS1 GP1) 
Complex explanations described processes which were automatic, occurring at the level of 
unfathomable system behaviour and were essentially non-adaptive and without purpose. They just 
happened. These explanations mirrored the chaotic narratives [33] which patients with MUS 
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commonly describe [34]. While other explanation types, particularly the rational adaptive, could be 
seen as a chalůĞŶŐĞƚŽƚŚĞŝŶĚŝǀŝĚƵĂů ?ƐŝŶƚĞŐƌŝƚǇ[21], complex explanations avoid this and thus may 
be more acceptable to patients for whom other explanations are unsatisfactory. However the 
implicit lack of agency in these accounts limits therapeutic options  W although acceptance or 
mindfulness based approaches could still be compatible with complex explanations.  
Explanations which did not fit a type tended to describe a simple relationship between cause(s) and 
the resulting symptom(s); symptoms were not situated within larger physiological or psychological 
processes. In MSS1 they mostly represent brief reprises of ideas discussed in more detail earlier, 
however in MSS2 they sometimes appeared with little surrounding context. 
ŶĚ/ƚŚŝŶŬ ?ǇŽƵŬŶŽǁ ?ŝƚĐĞƌƚĂŝŶůǇǁŽƵůĚŶ ?ƚďĞĐĂƵƐŝŶŐ ƚ ?ďƵƚŐĞƚƚŝŶŐǁŽƵŶĚƵƉĂďŽƵƚ
it won't help because of course when you get tense about things it drives the 
adrenalin system and that makes you sweat more. (MSS2, GP A) 
3.2 Explanation Components 
We identified three different categories of explanation components: Facts, Mechanisms and Causes. 
The components made up the content of the explanations and we coded them on a line-by-line 
basis, as opposed to the explanation types which were typically coded at the level of the 
explanation. A summary of each component is provided in Table 2.  
Facts represented general statements about physiological or psychological processes/adaptations 
within an explanation. Fact statements could relate to normal processes or to abnormal or 
maladaptive ones, but were ƉƌĞƐĞŶƚĞĚŝŶĂŶĂƵƚŚŽƌŝƚĂƚŝǀĞ “ƉŽƉƵůĂƌƐĐŝĞŶĐĞ ?ǁĂǇƌĂƚŚĞƌƚŚĂŶĂƐa 
specific interpretation of what was occurring within an individual. Facts were often used repeatedly 
for patients with similar symptoms by the same GP and largely represent scripts which can be reused 
with little customisation. Facts were identified in 72 (52.2%) explanations. 
In contrast, mechanisms were statements which attempted to interpret symptoms within the 
specific patient. They described processes by which symptoms were effected or perpetuated rather 
than more fundamental causes. Mechanisms sometimes built on facts but included more specific 
 “ǁŚĞŶyoccurs, then you / your boĚǇĚŽĞƐz ?ƐƚĂƚĞŵĞŶƚƐ ?tĞŝĚĞŶƚŝĨŝĞĚƐĞǀĞŶĐĂƚĞŐŽƌŝĞƐŽĨ
mechanism in the explanations: somatic, sensitisation, exhaustion, dissociation, alarm, attention and 
avoidance. These are listed with an example of each in table 2. These mechanism categories draw on 
understanding from sources ranging from somatic physiology, through neurophysiology to cognitive 
psychology.  
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Mechanisms were found in 129 (93.5%) of the ƉŚǇƐŝĐŝĂŶƐ ?ĞǆƉůĂŶĂƚŝŽŶƐ. In 75 (54.3%) instances 
there was a single mechanism, in 40 (29.0%) there were two and in 14 (10.1%) there were three or 
more. Physiological and neurophysiological mechanisms occurred most commonly: sensitisation 
occurred in 56 (40.6%) explanations, somatic mechanisms in 54 (39.1%) and exhaustion in 29 
(21.0%). Cognitive mechanisms were less common:  attention occurred in 30 (21.7%) explanations 
and avoidance in 19 (13.8%). Both dissociative and alarm mechanisms occurred infrequently in 7 and 
5 explanations respectively.  
Like mechanisms, cause components were specific to the individual and their story of illness. We 
identified three different cĂƵƐĞƐƚŚĂƚ'WƐĚŝƐĐƵƐƐĞĚĨŽƌƉĂƚŝĞŶƚƐ ?ƐǇŵƉƚŽŵƐ Wpredispositions (either 
heritable or trait), trigger events (e.g. viral infection or significant life event), and complex generative 
 ?Ğ ?Ő ?ŝŶƚĞƌĂĐƚŝŽŶŽĨĨĂĐƚŽƌƐŽƌ “ǀŝĐŝŽƵƐĐŝƌĐůĞƐ ? ?. Causes were identified in 88 (63.8%) ƉŚǇƐŝĐŝĂŶ ?Ɛ
explanations. Of these 54 had a single cause and 34 (24.6%) explanations had two or more causes. 
Table 3 demonstrates the number of different mechanism and cause categories present in each 
explanation, broken down by explanation type. This shows that rational adaptive explanations were 
more likely to have multiple causes and multiple mechanisms while automatic adaptive explanations 
were less likely to have any cause and usually included just a single mechanism.   
The three explanation components are illustrated within a full symptom explanation in Figure 1; in 
this explanation, the components are situated within an Automatic Adaptive narrative structure. 
 
4. Discussion & Conclusion 
4.1 Discussion 
4.1.1 Summary of main findings 
We developed an original taxonomy of explanations for persistent physical symptoms. This 
taxonomy extends existing models of clinical explanation [25] by providing a unifying framework of 
structure and components. The taxonomy provides new insights into the way that different 
explanation types convey different messages about responsibility and agency in relation to 
symptoms.  
4.1.2 Strengths and limitations 
This taxonomy was developed from explanations delivered to patients within a GP-led clinic 
specifically designed to help patients with persistent symptoms in which all clinical encounters were 
audio-recorded for detailed analysis. We included doctors with different levels of experience of and 
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training in delivering explanations and while the training and manual for the second study included 
examples of explanations, it was compiled before this taxonomy was developed. We used a constant 
comparative approach to coding explanations and explanation components. Several authors were 
actively involved in the coding process, through both hands-on coding and regular team meetings.  
The number and breadth of symptoms discussed meant we included explanations for a wide range 
of symptoms. The process of developing the taxonomy in one dataset, revising it in the and second 
and then re-coding all data could have resulted in a taxonomy which was over-fitted to the data. 
However, since developing the taxonomy we have carried out two informal validation steps. The first 
was to develop a range of explanations, using the types and components, for syndromes which did 
not feature in the clinics (such as non-cardiac chest pain and dysphonia) and check that these were 
also possible. For the second, two authors (VD & CB) have included elements of the taxonomy in 
teaching healthcare professionals and have found them to be well received. 
We recognise that this analysis has examined explanations in isolation from their context, the 
dialogue between patient and doctor and the various explanations and concerns that the patient 
brought to the encounter. The analysis of dialogue is reported elsewhere (den Boeft, submitted for 
publication) and both explanatory content and dialogue should be considered together in 
understanding the clinical usefulness of explanations. 
4.1.3 Comparison with existing research 
We considered using a number of existing consultation coding schemes [35-37]  but these largely 
focus on the structure of the consultation and communication within it rather than the detailed 
content of explanations. We found descriptive reports of explanation types used by patients [38] 
and doctors [25] but none had the detailed two-level structure which we found necessary to classify 
the explanations in our studies. Two studies have described conversation analysis of consultations 
for medically unexplained symptoms [21,31]. Both focused on patients ? responses to explanations 
for their symptoms; in the first, clinicians attempted to link physical symptoms to emotional stress or 
distress [21], while the other centred on variations around a single explanation of neuroendocrine 
arousal as the driver for symptoms [31]. Our approach of identifying a framework within which 
explanations can be constructed is compatible with a shift away from polemical explanation and 
counter-explanation and has the potential to facilitate formulations for shared explanation which 
have room for diverse components and values [14].  
4.2 Pr
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The taxonomy is designed to be suitable for further research and training. It is not limited to specific 
symptoms and can be adapted to a wide range of symptoms and clinical settings. In particular, it can 
be used to underpin studies which examine the value to patients of explanations of their 
 “ƵŶĞǆƉůĂŝŶĞĚ ?ƐǇŵƉƚŽŵƐ ?tŝƚŚŝŶĂƚƌĂŝŶŝŶŐĐŽŶƚĞǆƚŝƚĐĂŶďĞƵƐĞĚƚŽexamine ĐůŝŶŝĐŝĂŶƐ ?
explanations and help them develop new ones while cognisant of the features they are including. 
Studies using the taxonomy should seek to examine the impact of explanations in different 
situations: for instance complex explanations may be particularly helpful as a way of building 
common ground and shared understanding between doctors and patients with troublesome 
symptoms, but rational adaptive explanations may be more suited to promoting active symptom 
management and control.  Likewise some patients may prefer a particular explanation type: applying 
this may help build shared understanding and more personalised delivery of care. 
4.3 Conclusions  
This taxonomy of clinical explanations gives clinicians a framework of explanation types and 
components which can be used to provide patients with much-needed explanations. It offers new 
insights into the way that different explanation types convey different messages about responsibility 
and agency in relation to symptoms. The taxonomy represents a new and potentially valuable tool 
for research and teaching about clinical explanation. 
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Table 1, Summary of Explanation Types and Components identified in MSS1 & MSS2 symptom 
explanations 
Explanation Types 
x Rational Adaptive 
/ƚŝƐƵŶĚĞƌƐƚĂŶĚĂďůĞƚŚĂƚ ?ŝĨy ?ƚŚĞŶǇŽƵǁŽƵůĚz ?ďƵƚƚŚĂƚĐĂŶďĞĐŽŵĞƵŶŚĞůƉĨƵů 
x Automatic Adaptive 
Your body is designed ƚŚĂƚ ?ŝĨy ?ŝƚƐŚŽƵůĚĚŽz ?ďƵƚƐŽŵĞƚŝŵĞƐthat is the wrong response 
 ?ŝƚǁŽƌŬƐŝŶŽƚŚĞƌǁĂǇƐ ?ǁŚŝĐŚŵĞĂŶƐƚŚĂƚ ? 
x Complex 
zŽƵƌďŽĚǇŚĂƐĐŽŵƉůĞǆĂŶĚŝŶƚĞƌĂĐƚŝŶŐƐǇƐƚĞŵƐƚŽŵĂŶĂŐĞy ?ďƵƚƐŽŵĞƚŝŵĞƐƚŚĞƐĞĚŽŶ ?ƚ
ǁŽƌŬƉƌŽƉĞƌůǇ ?ĂƌĞŽƵƚŽĨďĂůĂŶĐĞ ?ŚĂǀĞĐĂƐĐĂĚĞŽƌĐǇĐůĞĞĨĨĞĐƚƐ ?ǁŚŝĐŚŵĞĂŶƐƚŚĂƚ ? 
  Explanation Components 
Facts Causes Mechanisms 
^ƚĂƚĞŵĞŶƚƐŽĨ “ƉŽƉƵůĂƌ
ƐĐŝĞŶĐĞ ?ǁŚŝĐŚĂƌĞŐĞŶĞƌĂů
rather than specific to the 
individual and their illness. 
Statements about candidate 
causal factors for the specific 
person and symptom. 
Statements about biological, 
neurocognitive, psychosocial 
ƉƌŽĐĞƐƐĞƐďǇǁŚŝĐŚĂƉĂƚŝĞŶƚ ?Ɛ
specific symptom(s) may arise 
or persist. 
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Table 2, Symptom mechanisms observed in MSS1 & MSS2 
Mechanism Description Example 
Somatic Specific bodily state, e.g. 
descriptions of abdominal 
symptoms, muscle tension 
 ?ŝĨǇŽƵƌŵƵƐĐůĞƐĂƌĞĂůǁĂǇƐƚĞŶƐĞ ?ƚŚĞŶƚŚĂƚ ?Ɛ
ĂůǁĂǇƐĐƌĞĂƚŝŶŐƉĂŝŶ ?a  
Sensitisation Central sensitisation and 
amplification 
 ?What seems to happen with some people, or 
with anybody after enough pain, is that the 
pain barrier starts to become less effective so 
ǇŽƵĐĂŶ ?ƚƐǁŝƚĐŚƉĂŝŶŽĨĨĂƚĂůů ?ĞǀĞŶǁŚĞŶŝƚ ?Ɛ
ďĞĞŶƚŚĞƌĞĨŽƌĂǀĞƌǇůŽŶŐƚŝŵĞĂŶĚŝƚ ?ƐŶŽƚ
telling you anything useful ?b  
Exhaustion Dimensions of fatigue (e.g. 
tiredness, sluggishness) 
 ?ǇŽƵƌƐůĞĞƉŝŶŐĐĞŶƚƌĞĂŶĚǇŽƵƌĂƌŽƵƐĂůĐĞŶƚƌĞ
buttons are not working as they should, 
they're not switching properly and ?you're left 
aroused at night and you're left...feeling kind 
ŽĨƵƌŐŚĂŶĚůŝŬĞǇŽƵ ?ƌĞŝŶĂĨŽŐ ? c 
Dissociation Dissociative light-
headedness, functional 
weakness, non-epileptic 
attacks 
 ?sometimes what happens is the brain 
becomes a bit overwhelmed by all these 
ŵĞƐƐĂŐĞƐĂŶĚŝƚ ?ƐĂůŵŽƐƚůŝŬĞŝƚŶĞĞĚƐƚŽƐŽƌƚ
of reset itself, and sometimes you can get 
these little episodes  ? you describe them as 
ƐŽƌƚŽĨŶŽƚƌĞĂůůǇďĞŝŶŐƚŚĞƌĞ ?ďĞŝŶŐƐŽƌƚŽĨ
ŽƵƚƐŝĚĞǇŽƵƌƐĞůĨ ?d  
Alarm Feeling of panic or 
palpitations 
 ?But in some people that alarm system goes 
off more readily, you know, it's almost like a 
false alarm that's going off, so if you 
experience something then your body is on an 
alert and that can cause you to feel a bit more 
sick than you should do ? d 
Attention Threat scanning, heightened 
awareness 
 ?ƚŽŬŝŶĚŽĨůĞĂƌŶƚŚĂƚǁŚĞŶǇŽƵ ?ƌĞŝůůǇŽƵ ?ǀĞ
got to watch out for things that  ?might make 
ǇŽƵŝůůĂŶĚŬŝŶĚŽĨǇŽƵ ?ǀĞŐŽƚƚŽƌĞĂĚƚŚĞƐŝŐŶƐ
very carefully which sometimes is really 
ŶĞĐĞƐƐĂƌǇǁŚĞŶǇŽƵ ?ƌĞǀĞƌǇŝůůďƵƚŬŝŶĚŽĨŐĞƚƐ
a bit less necessary when things are running 
smoothly, ďƵƚŝƚ ?ƐĂŚĂďŝƚ ? b 
Avoidance Staying away from or 
reducing activity levels 
 ?ĨĂƚŝŐƵĞ ?ƐĂ ?ĚŝĨĨŝĐƵůƚŽŶĞƚŽŽǀĞƌĐŽŵĞ ?Ƶŵ ?
ďĞĐĂƵƐĞǁŚĂƚ ?people tend to find is that 
being tired stops them doing things, and so 
ƚŚĞǇ ?ƌĞŶŽƚĚŽŝŶŐĂƐŵƵĐŚ ?ĂŶĚƚŚĂƚĐĂŶŵĂŬĞ
fatigue worse. e 
a GP A, MSS2 
b MSS1 GP 
c GP B, MSS2 
d GP D, MSS2 
e GP C, MSS2  
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Figure 1, Automatic Adaptive explanation incorporating Fact, Mechanism, and Causal components 
from MSS2 
  
GP D:  So normally we experience pain when we damage our body, 
when we injure our body, and what happens is that if you imagine you 
injured your knee, the pains in the knee would send messages initially 
up to the spinal column and then on up to the brain to say to the brain 
ƚŚĂƚƚŚĞŬŶĞĞŚĂƐďĞĞŶŝŶũƵƌĞĚ ? 
Fact 
...but what can happen in some people is that the signals from the 
nerves become amplified, they become louder if you like in the brain, so 
ƚŚĂƚƚŚŝŶŐƐƚŚĂƚƐŚŽƵůĚŶ ?ƚďĞƵŶĐŽŵĨŽƌƚĂďůĞďĞĐŽŵĞƉĂŝŶĨƵů ? 
 
Patient:  Okay. 
 
Mechanism: 
Sensitisation 
GP D:  And there are some theories as to why this happens.  We think 
that some people have a genetic likelihood to experience this chronic 
pain ? 
 
Cause: Predisposition 
 ?sometimes it follows some sort of trauma or physical insult and you 
mentioned that you thought a lot of this had started after you had your 
bowel operation which was obviously very traumatic the way it 
happened and the way it affected you for a number of years, so that 
may have been...  
 
Patient:  A trigger. 
 
GP D: ...a trigger for this ?  
Cause: Trigger Event 
 ?dŚĞƚŚŽƵŐŚƚŝƐƚŚĂƚŝƚ ?ƐĚƵĞƚŽĐŚĞŵŝĐĂůĐŚĂŶŐĞƐŝŶƚŚĞďƌĂŝŶĂŶĚĂƐĂ
result of those chemical changes, as I mentioned, the messages from 
the pain nerves are turned up, the volume is much louder than it should 
be, and there are a number of things that can help to turn it back down 
again.   
Mechanism: 
Sensitisation 
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Table 3, Number of mechanism and cause components present in each type of explanation 
 Rational Adaptive Automatic Adaptive           Complex 
 N % N % N % 
Mechanism categories       
        0 0 0 1 2.2 3 7.1 
        1 7 22.6 28 62.2 28 66.7 
        2 17 54.8 12 26.7 8 19 
      3+ 7 22.6 4 8.9 3 7.1 
Cause categories       
        0 7 22.6 30 66.7 7 16.7 
        1 16 51.6 11 24.4 18 42.9 
      2+ 8 25.8 4 8.9 17 40.5 
 
 
 
 
 
 
 
 
